Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-12-000905
Filing Date
2012-03-30
Accepted
2012-03-30 06:19:07
Documents
16
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K zk1211235.htm 10-K 2872966
2 EXHIBIT 3.1 exhibit31.htm EX-3.1 42651
3 EXHIBIT 3.2 exhibit32.htm EX-3.2 107164
4 EXHIBIT 4.5 exhibit45.htm EX-4.5 64517
5 EXHIBIT 23.1 exhibit231.htm EX-23.1 6260
6 EXHIBIT 31.1 exhibit311.htm EX-31.1 12633
7 EXHIBIT 31.2 exhibit312.htm EX-31.2 12890
8 EXHIBIT 32.1 exhibit321.htm EX-32.1 8993
9 EXHIBIT 32.2 exhibit322.htm EX-32.2 8954
16 filing10k.jpg GRAPHIC 12512
  Complete submission text file 0001178913-12-000905.txt   7234458

Data Files

Seq Description Document Type Size
10 INSTANCE DOCUMENT bicl-20111231.xml EX-101.INS 932644
11 TAXONOMY EXTENSION SCHEMA bicl-20111231.xsd EX-101.SCH 30521
12 TAXONOMY EXTENSION CALCULATION LINKBASE bicl-20111231_cal.xml EX-101.CAL 47183
13 TAXONOMY EXTENSION LABEL LINKBASE bicl-20111231_lab.xml EX-101.LAB 343549
14 TAXONOMY EXTENSION PRESENTATION LINKBASE bicl-20111231_pre.xml EX-101.PRE 125311
15 TAXONOMY EXTENSION DEFINITION LINKBASE bicl-20111231_def.xml EX-101.DEF 57886
Mailing Address BECK SCIENCE CENTER 8 HARTOM STREET, HAR HOTZVIM JERUSALEM L3 97775
Business Address BECK SCIENCE CENTER 8 HARTOM STREET, HAR HOTZVIM JERUSALEM L3 97775 972-2-548-6555
BIOCANCELL THERAPEUTICS INC. (Filer) CIK: 0001451980 (see all company filings)

EIN.: 204630076 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53708 | Film No.: 12725922
SIC: 2834 Pharmaceutical Preparations